THROMBODYNAMIC PROPERTIES OF FIBRIN CLOTS IN PATIENTS WITH IHD AFTER CORONARY BYPASS SURGERY
https://doi.org/10.52485/19986173_2021_2_18
Abstract
Aim. To study how the state of the hemostatic system changes in patients with coronary heart disease undergoing coronary artery bypass surgery.
Methods. Observations were performed on 58 patients with coronary artery disease (45 men and 13 women) aged 42 to 75 years. All patients underwent coronary artery bypass surgery. 48 operations were performed using cardiopulmonary bypass and 9 on a working heart using myocardial stabilizers. We studied platelet count, activated partial thromboplastin time (APTT), international normalized ratio (INR), fibrinogen level, and spatial growth of a fibrin clot.
Results. It was established that in patients with coronary heart disease in the early postoperative period, the dynamic properties of the fibrin clot decrease, which is mainly due to consumption coagulopathy. This, in particular, is evidenced by a decrease in the number of platelets, an elongation of activated partial thromboplastin time (APTT), an elongation of the international normalized ratio (INR), and a decrease in the level of fibrinogen. At the same time, the number of leukocytes sharply increases in patients and the number of red blood cells decreases. Before discharging patients from the hospital, the thrombodynamic properties of the clot sharply increase and in some parameters (size and density of the fibrin clot) exceed the indicators in the preoperative period. Negative correlations between the density of the clot and the total blood loss were found. It has been shown that, without exception, all formed blood elements affect the thrombodynamic properties of a clot, including its density and size.
Conclusion. The early postoperative period is favorable both for the occurrence of thromboembolic complications and bleeding, while before discharge of the patient from the hospital, there is a risk of thrombosis.
About the Authors
I. G. BogdanovRussian Federation
680009, Khabarovsk, 2В Krasnodarskaya str.
B. I. Kuznik
Russian Federation
672000, Chita, 39A Gorky str.
Y. N. Smolyakov
Russian Federation
672000, Chita, 39A Gorky str
O. A. Shcherbinina
Russian Federation
672000, Chita, 39A Gorky str.
N. V. Ignatova
Russian Federation
680009, Khabarovsk, 2В Krasnodarskaya str.
M. V. Bikbaeva
Russian Federation
680009, Khabarovsk, 2В Krasnodarskaya str
References
1. Barkagan Z.S., Momot A.P. Diagnostics and controlled therapy of the hemostatic system. Moscow : Newdiamed, 2008. 289 p. in Russian.
2. Bokarev I.N., Popova L.V., Kozlova T.V. Thrombosis and antithrombotic therapy in clinical practice. Moscow : MIA, 2009. 512 p. in Russian.
3. Bokeria L.A. Hemostasis system and blood rheology in patients with coronary heart disease of a cardiac surgical profile, diagnostic and control methods. Moscow : NTSSSH im. A.N. Bakuleva RAMS, 2017.32 p. in Russian.
4. Drinane M.C. Plasminogen and plasmin activity in patients with coronary artery disease. Journal of Thrombosis and Haemostasis, 2006. 4(6). 1288-95. doi: 10.1111/j.1538-7836.2006.01979.x.
5. Guest J.F., Watson H.G., Limaye S. Modeling the cost-effectiveness of prothrombin complex concentrate compared with fresh frozen plasma in emergency warfarin reversal in the United kingdom. Clinical Therapeutics. 2010. 32(14). 2478-2493. doi: 10.1016/j.clinthera.2011.01.011.
6. Lokshin L.S., Lurie G.O., Dementieva I.I. Artificial and auxiliary blood circulation in cardiovascular surgery. Moscow : Scientific Center of Surgery RAMS, 1998.221 p. in Russian.
7. Mamaeva S.A., Pichugin V.V., Bogush A.V., Pichugina M.V., Volkova N.A. The use of the drug Prothromplex 600 for the treatment of bleeding during and after reconstructive operations on the heart and blood vessels in conditions of cardiopulmonary bypass. Tromboz, gemostaz i reologija = Thrombosis, hemostasis and rheology. 2012. 49 (1). 47. in Russian.
8. Panteleev M.A., Balandina A.N., Soshitova N.P., Galstyan G.M., Emelianenko V.M., Vorobyev A.I., Ataullakhanov F.I. Spatial dynamics of hemostasis and thrombosis: theory and practice. Tromboz, gemostaz i reologija = Thrombosis, hemostasis and rheology. 2010. (4). 48-60. in Russian.
9. Zubairov D.M., Zubairova L.D. Microvesicles in the blood, function and their role in thrombosis. Moscow : Geotar-Media, 2009.168 p. in Russian.
10. Kuznik B.I., Sturov V.G., Levshin N.Yu., Maksimova O.G., Kudlay D.A. Hemorrhagic and thrombotic diseases and syndromes in children and adolescents. Novosibirsk: Nauka, 2019. 456 p. in Russian.
11. Chakraborty M., Tarasovetc E.V., Zaytsev A.V., Godzi M., Figueiredo A.C., Ataullakhanov F.I., Grishchuk E.L. Microtubule end conversion mediated by motors and diffusing proteins with no intrinsic microtubule end-binding activity. Nat Commun. 2019. 10(1). 1673. doi: 10.1038/s41467-019-09411-7.
12. Panteleev M.A., Hemker H.C. Global/integral assays in hemostasis diagnostics: promises, successes, problems and prospects. Thromb J. 2015 Jan 28. 13(1). 5. doi: 10.1186/s12959-014-0032-y. eCollection 2015.
13. Moller L., Kristensen T.S. Plasma fibrinogen and ischemic heart disease risk factors. Arteriosclerosis and thrombosis: a journal of vascular biology. 1991. 11(2). 344-347. doi: 10.1161/01.ATV.11.2.344.
14. Nakamura S., Imamura T., Okamoto K. Tissue factor in neutrophils: yes! Journal of Thrombosis and Haemostasis. 2004. 2(2). 214-7. doi: 10.1111/j.1538-7836.2004.00548.x.
15. Østerud B. The role of platelets in decrypting monocyte tissue factor. Disease-a-month. 2003. 49(1). 7-13. doi: 10.1053/shem.2001.29508.
16. Østerud B., Unruh D., Olsen J.O., Kirchhofer D., Owens A.P. 3rd, Bogdanov V.Y. Procoagulant and proinflammatory effects of red blood cells on lipopolysaccharide-stimulated monocytes. J Thromb Haemost. 2015 Sep. 13(9). 1676-82. doi: 10.1111/jth.13041. Epub 2015 Jul 27.
17. Stepanov A.V., Davydov S.O., Kuznik B.I., Guseva E.S., Smolyakov Yu.N. The effect of moderate physical activity on the concentration of the adhesive molecule JAM-A, estrogen, progesterone, prolactin and lipid metabolism in women suffering from hypertension. Zabajkal'skij medicinskij vestnik = Trans-Baikal Medical Bulletin. 2019. (4): 122-127. in Russian.
18. Chen V.M., Hogg P.J. Allosteric disulfide bonds in thrombosis and thrombolysis. Journal of Thrombosis and Haemostasis. 2006. 4(12). 2533-41. doi: 10.1111/j.1538-7836.2006.02236.x.
19. Balandina A.N., Serebriyskiy I.I., Poletaev A.V., Polokhov D.M., Gracheva M.A., et al. Thrombodynamics-A new global hemostasis assay for heparin monitoring in patients under the anticoagulant treatment. PLoS One. 2018. 13(6). e0199900. doi: 10.1371/journal.pone.0199900.
Review
For citations:
Bogdanov I.G., Kuznik B.I., Smolyakov Y.N., Shcherbinina O.A., Ignatova N.V., Bikbaeva M.V. THROMBODYNAMIC PROPERTIES OF FIBRIN CLOTS IN PATIENTS WITH IHD AFTER CORONARY BYPASS SURGERY. Transbaikalian Medical Bulletin. 2021;(2):18-28. (In Russ.) https://doi.org/10.52485/19986173_2021_2_18